Prince Joshua S. 4
4 · Vistagen Therapeutics, Inc. · Filed Jan 5, 2026
Insider Transaction Report
Form 4
Prince Joshua S.
Chief Operating Officer
Transactions
- Award
Common Stock
2025-12-31$0.56/sh+4,386$2,468→ 15,249 total
Footnotes (1)
- [F1]Represents acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d).